SONY vs VIR
SONY (SONY) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
SONY (SONY) common stock.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
SONY does not have a complete income-statement cache yet.
Latest reported VIR revenue for 2026-06-30 was $238.9M. Net income was -$45.6M. VIR currently screens at market cap $1.45B.
SONY currently screens at market cap $0. VIR currently screens at market cap $1.45B.
Not investment advice. Open the SONY and VIR stock pages for the full models.
Not investment advice.